Skip to Content

Join the 'Chronic Spasticity' group to help and get support from people like you.

Chronic Spasticity News

Many Misdiagnosed With MS

Posted 13 days ago by Drugs.com

THURSDAY, April 11, 2019 – Almost one in five multiple sclerosis patients may be misdiagnosed with the autoimmune disease, according to a new study. Of 241 previously diagnosed multiple sclerosis (MS) patients referred to two major Los Angeles medical centers for treatment, nearly 18% did not actually have the autoimmune disease, the researchers found. Those patients spent an average of nearly...

Mavenclad Approved for Multiple Sclerosis

Posted 2 Apr 2019 by Drugs.com

MONDAY, April 1, 2019 – Mavenclad (cladribine) tablets have been approved by the U.S. Food and Drug Administration to treat relapsing multiple sclerosis (MS) in adults. An agency news release said the drug is recommended for people who have had an inadequate response to, or are unable to tolerate, another medication approved for MS. Mavenclad is not sanctioned for a form of MS called clinically...

Second New MS Drug Mavenclad (Cladribine) Secures FDA Approval

Posted 1 Apr 2019 by Drugs.com

MONDAY, April 1, 2019 – The U.S. Food and Drug Administration has approved another new multiple sclerosis drug – the second in one week. Mavenclad (cladribine) pills can be used to treat relapsing forms of MS in adults, including relapsing-remitting disease and active secondary progressive disease. The drug is not recommended for MS patients with a course of the disease known as clinically...

Common MS Treatment, Beta Interferon, Can Bring Longer, Healthier Life

Posted 28 Mar 2019 by Drugs.com

THURSDAY, March 28, 2019 – An older but still common multiple sclerosis (MS) treatment has an unexpected perk: It not only quells symptoms, but patients may also live longer. New research revealed that patients taking a beta interferon drug for more than three years were likely to live longer than those who took one for a shorter time or who didn't take one at all. "This study was the first and...

Mayzent Approved for Relapsing MS

Posted 28 Mar 2019 by Drugs.com

WEDNESDAY, March 27, 2019 – Mayzent (siponimod) pills have been approved by the U.S. Food and Drug Administration for adults with relapsing multiple sclerosis (MS). "Multiple sclerosis can have a profound impact on a person's life," said Dr. Billy Dunn, director of the agency's Division of Neurology Products. MS is an autoimmune disease of the central nervous system that disrupts communication...

Managing MS

Posted 23 Mar 2019 by Drugs.com

FRIDAY, March 22, 2019 – Proper treatment can help people with multiple sclerosis (MS) contend with their disease, an expert says. "Patients get a predisposed feeling that their life is doomed. That it's going to be a complicated life, which isn't necessarily so," said Dr. Cary Twyman, a neurologist at Penn State Health. "There are many misconceptions and false information about MS on the...

Study Disputes Pregnancy Link to MS Relapses

Posted 10 Mar 2019 by Drugs.com

THURSDAY, March 7, 2019 – A new study challenges the long-held belief that multiple sclerosis (MS) can flare up right after pregnancy in women with the relapsing-remitting form of the disease. In that type of MS, symptoms arise, then go into periods of remission. "These results are exciting, as MS is more common among women of childbearing age than in any other group," explained study author Dr....

Could Too Much Soda Worsen MS?

Posted 6 Mar 2019 by Drugs.com

TUESDAY, March 5, 2019 – Popping open too many sodas or other sweetened beverages each day might worsen symptoms for people with multiple sclerosis, new research suggests. It's important to note that the small study could only point to an association – it couldn't prove that high soda intake causes MS symptoms to get worse. But study author Dr. Elisa Meier-Gerdingh said it couldn't hurt to cut...

MS Drug Costs Skyrocket After Medicare Rule Change: Study

Posted 6 Feb 2019 by Drugs.com

WEDNESDAY, Feb. 6, 2019 – Medicare rule changes could trigger a spike in out-of-pocket drug costs for patients with multiple sclerosis (MS). Due to rules that restrict access and require patients to cover more of the cost, those without low-income subsidies can expect to spend almost $6,900 a year out of pocket for MS medicines, researchers reported. "It's a dysfunctional market that lacks the...

Health Tip: Managing Fatigue Associated With MS

Posted 25 Jan 2019 by Drugs.com

-- Fatigue occurs in more than 80 percent of people with MS, the National Multiple Sclerosis Society says. The society suggests including these approaches to managing fatigue: Regulate your sleep, which might involve treating other MS symptoms that interfere with sleep (ie., spasticity, urinary problems). Psychological interventions, such as stress management, relaxation training, membership in...

People With Movement Disorders May Become Immune to Botox Therapy

Posted 29 Dec 2018 by Drugs.com

FRIDAY, Dec. 28, 2018 – Some people who receive botulinum toxin injections for disorders that cause muscle tightness and contractions develop resistance to the treatment, researchers say. The new study included nearly 600 patients with dystonia or spasticity who had been receiving botulinum toxin type A (commonly known as "Botox") for about three to five years. The researchers found that about...

FDA Warns of Rare Stroke Risk With MS Drug Lemtrada (Alemtuzumab)

Posted 5 Dec 2018 by Drugs.com

WEDNESDAY, Dec. 5, 2018 – A new warning has been added to the multiple sclerosis drug Lemtrada (alemtuzumab) after rare reports of patients suffering strokes and tears in the lining of the arteries in the head and neck, the U.S. Food and Drug Administration said. Most patients with these problems – which can lead to permanent disability and death – developed symptoms within a day of receiving...

Low-Dose Aspirin May Help Fight MS, Mouse Study Hints

Posted 28 Nov 2018 by Drugs.com

TUESDAY, Nov. 27, 2018 – Although the findings are so far only in mice, studies suggest that aspirin – even the "low-dose" variety – might help counter multiple sclerosis. Multiple sclerosis (MS) is an autoimmune disorder where aberrant immune system T-cells attack and destroy the protective myelin protein sheath that coats nerves. This causes gradual debilitation for the more than 2.3 million...

Medical Marijuana Might Help MS Patients, But Uncertainty Remains

Posted 12 Oct 2018 by Drugs.com

FRIDAY, Oct. 12, 2018 – Medical products derived from marijuana might have a mild benefit in treating symptoms of multiple sclerosis, based on reports from patients. Drugs containing the major chemical compounds in cannabis are associated with a limited and mild reduction in muscle contractions, bladder dysfunction and pain, based on patient self-assessments from clinical trials included in a...

For Many With MS, Well-Being Increases With Age

Posted 28 Sep 2018 by Drugs.com

FRIDAY, Sept. 28, 2018 – Living with a potentially disabling condition like multiple sclerosis (MS) can be difficult, but new research suggests patients get better at dealing with it over time. "There's an aging paradox in healthy adults. We expect people who are older to be more depressed and anxious because of aging processes [such as physical aches and pain and losing friends and family], but...

Ask a Question

Further Information

Related Drug Support Groups

baclofen, Botox